• Group of action: Agents affecting the digestive system and metabolism

  • Active ingredient: Ranitidine hydrochloride

  • Dosage form: Film-coated tablets

  • Pharmacotherapeutic group: Agents for treatment of peptic ulcer and gastroesophageal reflux disease. H2 receptor antagonists. Ranitidine.

  • ATC code: A02BA02

  • RX/OTC: RX

Peptic ulcer and duodenal ulcers, not associated with Helicobacter pylori (in exacerbation phase), including ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs);

  1. functional dyspepsia;
  2. chronic gastritis with increased acid-forming function of the stomach in exacerbation phase;
  3. gastroesophageal reflux disease (to relieve symptoms) abo reflux esophagitis.

Individual hypersensitivity to the drug; the presence of malignant diseases of the stomach, liver cirrhosis with portosystemic encephalopathy in anamnesis; severe renal insufficiency.

Film-coated tablets from light orange to orange in color, with a biconvex surface. At the break is seen under a magnifying glass core surrounded by a continuous layer

3 years

Keep out of reach of children in the original packaging at a temperature not exceeding 25 ° C.